Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens

Matsumoto T

Clinical Pharmacology: Advances and Applications 2014, 6:139-148

Published Date: 26 September 2014